# Leadership, Planning and Evaluation

> **NIH NIH P30** · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2024 · $188,575

## Abstract

LEADERSHIP, PLANNING AND EVALUATION: ABSTRACT
The Stephenson Cancer Center (SCC) conducts formal planning and evaluation activities, under the oversight
of the SCC director and senior leadership team, to advance its mission of eliminating cancer in Oklahoma
(SCC catchment area) and beyond. Planning and evaluation are critically important for a matrix cancer center
like the SCC to ensure optimal coordination, integration, and effectiveness of SCC activities and resource
allocation. The following core strategic priorities inform the goals, tactics, and metrics for all SCC research
components: 1) enhancing breadth, depth, and impact of cancer-focused research; 2) fostering the translation
of discoveries into the clinical or community setting; 3) designing and conducting hypothesis-driven trials to
improve outcomes for people with or at risk for cancer; 4) promoting intra- and inter-programmatic collaboration
and transdisciplinary team science; 5) enhancing COE to address priority cancers and cancer problems
prevalent in the SCC catchment area; 6) increasing training and mentorship opportunities for students and
faculty; and 7) enhancing the presence of underrepresented minority persons and women among SCC
leadership and membership, and in pipeline programs. For oversight, planning, and evaluation of research
activities, SCC Director Robert Mannel, MD has assembled an experienced senior leadership team of
associate directors (ADs) who oversee the following functions: basic research (Danny Dhanasekaran, PhD);
translational research (Priyabrata Mukherjee, PhD); clinical research (Kathleen Moore, MD); community
outreach and engagement (Mark Doescher, MD); education, training, and career enhancement (Rajagopal
Ramesh, PhD); diversity, equity, and inclusion (Joan Walker, MD); and research administration (Wade
Williams, PhD).
Since Mannel’s appointment as SCC director in 2006, strategic planning and evaluation has played a central
role in the development of the SCC. The standing Research Leadership Committee (RLC) and Research
Steering Committee (RSC), which are comprised of leaders for all research components at the SCC, provide
regular forums for planning and evaluating progress. In addition, research leadership is well represented in
SCC clinical planning and evaluation. External input from scientific and community advisory boards augment
these planning and evaluation activities. New strategic initiatives emerging from planning discussions during
the reporting period include: research program realignment (2018); strategic partnerships with the Oklahoma
Center for Geroscience (2018) and Harold Hamm Diabetes Center (2019); new initiatives to enhance SCC
research focused on catchment area priority cancers and prevalent cancer problems (2019); increased
engagement with OU Norman to foster cancer-focused research and collaborations (2020); establishing a new
AD position for diversity, equity, and inclusion, and broad planning for how to enhance DEI among SCC...

## Key facts

- **NIH application ID:** 10838571
- **Project number:** 5P30CA225520-07
- **Recipient organization:** UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
- **Principal Investigator:** ROBERT S. MANNEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $188,575
- **Award type:** 5
- **Project period:** 2018-05-01 → 2028-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10838571

## Citation

> US National Institutes of Health, RePORTER application 10838571, Leadership, Planning and Evaluation (5P30CA225520-07). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10838571. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*